Indivior Pharmaceuticals, Inc. INDV Rest of World — Net revenue
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Indivior Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Indivior Pharmaceuticals, Inc. ’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Indivior Pharmaceuticals, Inc. 's rest of world — net revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Indivior Pharmaceuticals, Inc. 's rest of world — net revenue?
- Indivior Pharmaceuticals, Inc. (INDV) reported rest of world — net revenue of $45M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc. 's rest of world — net revenue changed year-over-year?
- Indivior Pharmaceuticals, Inc. 's rest of world — net revenue increased by 2.3% year-over-year, from $44M to $45M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc. 's rest of world — net revenue?
- Over 3 years (2022 to 2025), Indivior Pharmaceuticals, Inc. 's rest of world — net revenue has grown at a 3.2% compound annual growth rate (CAGR), from $169M to $186M.
- What does rest of world — net revenue mean?
- This metric represents the total net sales generated from pharmaceutical products within all geographic regions outside of the company's primary domestic and secondary core markets. It reflects the company's ability to commercialize its portfolio of substance use disorder and mental health treatments on a global scale. Tracking this revenue stream helps investors assess the geographic diversification and international growth potential of the business.